BMS Holdings Bhd remains cautiously optimistic about its prospects for the remainder of the financial year ending June 30, 2026 (FY26).

This robust institutional backing and financial strength have enabled CCIG to transcend traditional manufacturing, ...

Bristol-Myers Squibb Company hits a 52-week high as Breyanzi sales surge and AI imaging expands. Click for this updated look at BMY stock prospects.

Aisle containment is no longer a static wall – but an intelligent asset that actively drives efficiency forward ...

The veterinarian-owned startup empowers a network of veterinarians who provide in-home euthanasia to ease the passing ...

FDA has accepted the NDA for BMS's Iberdomide, an oral agent targetting relapsed/refractory multiple myeloma.

The number of industrial control system (ICS) security advisories published in 2025 topped 500 for the first time since records began, with the severity of vulnerabilities also increasing, according ...

After notching its fifth straight record-breaking sales year in the US, Hyundai has no plans of slowing down. The ...

Hyundai's Georgia metaplant aims to help company produce over 80% of its US-sold vehicles domestically by 2030, focus on EV sales, battery innovation ...

A new study highlights the critical role of advanced AI-integrated battery management system technologies in monitoring, optimizing, and predicting battery performance for reliable and sustainable ...

Genetically modified immune cells can offer precious additional time to patients with advanced multiple myeloma. However, these therapies lose their impact as the molecules on cancer cells that immune ...